Bioprocessing and Cell and Gene Therapies
Bioprocessing or biological manufacturing is the practice of using living organisms, like bacteria, yeast, mammalian cells or their components (enzymes) to create new, high value products. It is where biology meets chemical engineering in the real world of large-scale, industrial production.
Innovations in Cell and Gene Therapy
One of the major applications of bioprocessing is biopharmaceutical manufacturing which overlaps with and is now a significant extension of the traditional pursuits of the life sciences/drug discovery/pharmaceutical sector.
Bioprocessing has become a recognised and intrinsic part of the production of vaccines, monoclonal antibodies, insulin and new cell and gene therapies which are at the forefront of innovative discoveries revolutionising the treatment of humans beyond symptom management in order to address the root cause of genetic and acquired diseases.
Global Market Growth in Bioprocessing and Gene Therapy
Globally the bioprocessing sector is predicted to be worth $277 billion a year by 2035 and Cell and Gene Therapy revenues are predicted to rise 20% a year each year from their current $31 billion annual revenue figure.
Our strength is in giving our customers access to the best Sales, Applications or Service Engineering talent out there and turn these stars into active candidates who want to talk to you. To do this we don’t rely on the small percentage of the market actively looking for a new role.
